Elevated levels of plasma inactive stromal cell derived factor-1a predict long-term adverse outcomes in diabetic patients with coronary artery disease

2 September 2024 (14:00 - 14:40)
Organised by: Logo
Congress Presentation Part of: Metabolic syndrome and heart disease (2) Percutaneous Coronary Intervention (PCI) and Surgery ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology